Eating disorders in children with rheumatic diseases
https://doi.org/10.47360/1995-4484-2025-510-516
Abstract
The high comorbidity of eating disorders, especially anorexia nervosa, and various autoimmune diseases is well known but only a few foreign publications address the prevalence and course of eating disorders in children with immuneinflammatory rheumatic diseases, while in the domestic scientific press the problem of comorbidity of eating disorders and rheumatic diseases isn’t still discussed, neither in children nor in adult patients
The aim of this review is to try to fill this gap in the Russian-language scientific literature by summarizing the data available in foreign publications on eating disorders in patients suffering from juvenile-onset systemic lupus erythematosus, juvenile idiopathic arthritis, juvenile fibromyalgia and other syndromes of chronic musculoskeletal pain, as well as hyperuricemia.
About the Authors
A. V. Santimov
Saint-Petersburg State Pediatric Medical University
Russian Federation
Competing Interests:
Russian Federation
Andrei V. Santimov
194100, Saint-Petersburg, Litovskaya str., 2
Competing Interests:
None
S. V. Grechanyi
Saint-Petersburg State Pediatric Medical University
Russian Federation
Competing Interests:
Russian Federation
Severin V. Grechanyi
194100, Saint-Petersburg, Litovskaya str., 2
Competing Interests:
None
G. A. Novik
Saint-Petersburg State Pediatric Medical University
Russian Federation
Competing Interests:
Russian Federation
Gennady A. Novik
194100, Saint-Petersburg, Litovskaya str., 2
Competing Interests:
None
M. V. Zhdanova
Saint-Petersburg State Pediatric Medical University
Russian Federation
Competing Interests:
Russian Federation
Marina V. Zhdanova
194100, Saint-Petersburg, Litovskaya str., 2
Competing Interests:
None
N. V. Slizovskii
Saint-Petersburg State Pediatric Medical University
Russian Federation
Competing Interests:
Russian Federation
Nikolay V. Slizovskii
194100, Saint-Petersburg, Litovskaya str., 2
Competing Interests:
None
References
1. Robatto AP, Cunha CM, Moreira LAC. Diagnosis and treatment of eating disorders in children and adolescents. J Pediatr (Rio J). 2024;100(Suppl 1):88-96. doi: 10.1016/j.jped.2023.12.001
2. Salari N, Heidarian P, Tarrahi MJ, Mansourian M, Canbary Z, Daneshkhah A, et al. Global prevalence of eating disorders in children: A comprehensive systematic review and meta-analysis. Ital J Pediatr. 2025;51(1):107. doi: 10.1186/s13052-025-01958-0
3. Balakireva EE. Eating disorders in children and adolescents. Psychiatry (Moscow). 2013;60(4):16-21 (In Russ.).
4. Balakireva EE. Eating disorders in children and adolescents. Psychiatry and Psychopharmacotherapy. 2020;22(4):38-41 (In Russ.).
5. Dursun OB, Esin İS, Akıncı MA, Karayağmurlu A, Turan B, Özhan Aşıkhasanoğlu E. The prevalence of childhood mental disorders in different habitations: Are we underestimating their prevalence in rural areas? Nord J Psychiatry. 2020;74(3):201-207. doi: 10.1080/08039488.2019.1689295
6. Lieberman M, Houser ME, Voyer AP, Grady S, Katzman DK. Children with avoidant/restrictive food intake disorder and anorexia nervosa in a tertiary care pediatric eating disorder program: A comparative study. Int J Eat Disord. 2019;52(3):239-245. doi: 10.1002/eat.23027
7. Zerwas S, Larsen JT, Petersen L, Thornton LM, Quaranta M, Koch SV, et al. Eating disorders, autoimmune, and autoinflammatory disease. Pediatrics. 2017;140(6):e20162089. doi: 10.1542/peds.2016-2089
8. Hedman A, Breithaupt L, Hübel C, Thornton LM, Tillander A, Norring C, et al. Bidirectional relationship between eating disorders and autoimmune diseases. J Child Psychol Psychiatry. 2019;60(7):803-812. doi: 10.1111/jcpp.12958
9. Sirufo MM, Magnanimi LM, Ginaldi L, De Martinis M. Anorexia nervosa and autoimmune comorbidities: A bidirectional route? CNS Neurosci Ther. 2022;28(12):1921-1929. doi: 10.1111/cns.13953
10. Khavkin AI, Odinaeva ND, Nalyotov AV, Kondratyeva EI, Marchenko NA, Matsynin AN, et al. Celiac disease and eating disorders are a bidirectional relationship of diseases. Pediatric Pharmacology. 2025;22(2):135-140 (In Russ.). doi: 10.15690/pf.v22i2.2882
11. Lisitsyna TA, Veltishchev DYu. Mental disorders in patients with rheumatic diseases: Diagnosis and treatment. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2015;53(5):512-521 (In Russ.). doi: 10.14412/1995-4484-2015-512-521
12. Lisitsyna TA, Vel’tishchev DYu. Diagnostics and treatment of mental disorders in patients with rheumatic diseases. Therapy. 2017;4(14):23-29 (In Russ.).
13. Lisitsyna TA, Veltishchev DY, Seravina OF, Kovalevskaya OB, Starovoytova MN, Desinova OV, et al. Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases. Terapevticheskii arkhiv. 2018;90(5):30-37 (In Russ.). doi: 10.26442/terarkh201890530-37
14. Lisitsyna TA, Veltishchev DYu, Nasonov EL, Lila AM. Psychiatric aspects of spondyloarthritis. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2020;58(6):716-724 (In Russ.). doi: 10.47360/1995-4484-2020-716-724
15. Lisitsyna TA, Veltishchev DYu, Lila AM, Nasonov EL. Interleukin 6 as a pathogenic factor mediating clinical manifestations and a therapeutic target for rheumatic diseases and depressive disorders. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2019;57(3):318-327 (In Russ.). doi: 10.14412/1995-4484-2019-318-327
16. Rukavishnikov GV, Mazurov VI, Neznanov NG, Malyshko LV, Mazo GE. Rheumatoid arthritis and depression: Common pathophysiological mechanisms. Clinical Medicine (Russian Journal). 2019;97(8-9):586-591 (In Russ.). doi: 10.34651/0023-2149-2019-97-8-9-586-591
17. Mazo GE, Rukavishnikov GV. Pathophysiological mechanisms of depression: Focusing on leptin. Mental Health. 2016;14(6):72-78 (In Russ.).
18. Kaleda MI, Nikishina IP. Neuropsychiatric involvement in juvenileonset systemic lupus erythematosus. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2020;58(4):437- 442 (In Russ.). doi: 10.47360/1995-4484-2020-437-442
19. Kaleda MI, Nikishina IP, Glukhova SI, Stepanenko NYu. Neuropsychiatric disorders in juvenile-onset systemic lupus erythematosus: Results from a retrospective study. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2020;58(2):171-177 (In Russ.). doi: 10.14412/1995-4484-2020-171-177
20. Kuchinskaya EM, Yakovleva YuA, Rakova MA, Lyubimova NA, Suspitsin EN, Kоstik MM. Systemic lupus erythematosus with neuropsychiatric manifestations in a child: Case report and review of the international recommendations for the diagnostics and management. Russian Bulletin of Perinatology and Pediatrics. 2021;66(1):98-105 (In Russ.). doi: 10.21508/1027-4065-2021-66-1-98-105
21. Santimov AV, Grechanyi SV, Novik GA. Mental disorders in children with rheumatic diseases. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2024;62(1):109-117 (In Russ.). doi: 10.47360/1995-4484-2024-109-117
22. Santimov AV. The role of diet in the development and treatment of rheumatic diseases in children. Children’s Medicine of the North-West. 2024;12(4):99-117 (In Russ.). doi: 10.56871/CmN-W.2024.65.19.007
23. Bambery P, Malhotra S, Kaur U, Chadda R, Deodhar SD. Anorexia nervosa in a patient with systemic lupus erythematosus. Rheumatol Int. 1987;7(4):177-179. doi: 10.1007/BF00270367
24. Sloan D, Gallagher S, Walsh N. Anorexia nervosa complicating systemic lupus erythematosus (SLE). Ir Med J. 1998;91(3):97.
25. Toulany A, Katzman DK, Kaufman M, Hiraki LT, Silverman ED. Chicken or the egg: Anorexia nervosa and systemic lupus erythematosus in children and adolescents. Pediatrics. 2014;133(2):e447-e450. doi: 10.1542/peds.2012-3048 26. Xu M, MacNeal LA, Wittman BJ, Rutledge JC. Is identification
26. of lupus erythematosus cells still useful? A case report. Pediatr Dev Pathol. 2016;19(5):424-427. doi: 10.2350/15-08-1695-CR.1
27. Nakamura M, Tanaka S, Inoue T, Maeda Y, Okumiya K, Esaki T, et al. Systemic lupus erythematosus and Sjögren’s syndrome complicated by conversion disorder: A case report. Kurume Med J. 2018;64(4):97-101. doi: 10.2739/kurumemedj.MS644005
28. Hyla-Klekot L, Wolny A, Janas-Kozik M, Koszutski T. Anorexia nervosa and juvenile lupus erythematosus in a 16-year-old female patient – common disease origin or random coincidence? Cent Eur J Immunol. 2021;46(1):127-132. doi: 10.5114/ceji.2021.104326
29. Wang JX, Adamson J, Major GA. Contemporaneous onset of systemic lupus erythematosus and severe eating disorder; neither the chicken nor the egg. J Paediatr Child Health. 2024;60(2-3):67- 68. doi: 10.1111/jpc.16523
30. Grammatikopoulou MG, Syrmou V, Lioliopoulou ML, Gkiouras K, Simopoulou T, Katsiari CG, et al. Anorexia nervosa in juvenile systemic lupus erythematosus (SLE): A causality dilemma. Children (Basel). 2023;10(4):697. doi: 10.3390/children10040697
31. Delcoigne B, Horne A, Reutfors J, Askling J. Risk of psychiatric disorders in juvenile idiopathic arthritis: Population- and siblingcontrolled cohort and cross-sectional analyses. ACR Open Rheumatol. 2023;5(5):277-284. doi: 10.1002/acr2.11549
32. Pedersen MJ, Høst C, Hansen SN, Deleuran BW, Bech BH. Psychiatric morbidity is common among children with juvenile idiopathic arthritis: A national matched cohort study. J Rheumatol. 2024;51(2):181-188. doi: 10.3899/jrheum.2023-0084
33. Barber J, Sheeran T, Mulherin D. Anti-tumour necrosis factor treatment in a patient with anorexia nervosa and juvenile idiopathic arthritis. Ann Rheum Dis. 2003;62(5):490-491. doi: 10.1136/ard.62.5.490
34. Beutler B, Greenwald D, Hulmes JD, Chang M, Pan YC, Mathison J, et al. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature. 1985;316(6028):552- 554. doi: 10.1038/316552a0
35. Roubenoff R, Roubenoff RA, Ward LM, Holland SM, Hellmann DB. Rheumatoid cachexia: Depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol. 1992;19(10):1505-1510.
36. Holden RJ, Pakula IS. The role of tumor necrosis factor-alpha in the pathogenesis of anorexia and bulimia nervosa, cancer cachexia and obesity. Med Hypotheses. 1996;47(6):423-438. doi: 10.1016/s0306-9877(96)90153-x
37. Bou Khalil R, de Muylder O, Hebborn FL. Treatment of anorexia nervosa with TNF-α down-regulating agents. Eat Weight Disord. 2011;16(4):e300. doi: 10.1007/BF03327476
38. Lisitsyna TA, Abramkin AA, Veltishchev DYu, Seravina OF, Kovalevskaya OB, Borisova AB, et al. Efficacy of olokizumab against comorbid depressive disorder in patients with rheumatoid arthritis: Preliminary results of the study. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2023;61(2):188-198 (In Russ.). doi: 10.47360/1995-4484-2023-188-198
39. Alexeeva EI, Dvoryakovskaya TM, Zholobova ES, Krekhova EA, Raupov RK, Matkava VG, et al. Results of a 24-week open-label phase II study of olokizumab in adolescent patients with polyarticular juvenile idiopathic arthritis. Clinical Practice in Pediatrics. 2024;19(6):7-17 (In Russ.). doi: 10.20953/1817-76462024-6-7-17
40. Santimov AV, Grechanyi SV, Novik GA. Secondary fibromyalgia in children with immune-inflammatory rheumatic diseases. Modern Rheumatology Journal. 2024;18(3):99-106 (In Russ.). doi: 10.14412/1996-7012-2024-3-99-106
41. Deere KC, Clinch J, Holliday K, McBeth J, Crawley EM, Sayers A, et al. Obesity is a risk factor for musculoskeletal pain in adolescents: Findings from a population-based cohort. Pain. 2012;153(9):1932-1938. doi: 10.1016/j.pain.2012.06.006
42. da Silva SG, Sarni RO, de Souza FI, Molina J, Terreri MT, Hilário MO, et al. Assessment of nutritional status and eating disorders in female adolescents with fibromyalgia. J Adolesc Health. 2012;51(5):524-527. doi: 10.1016/j.jadohealth.2012.02.018
43. Miyamae T, Isozaki J, Kikuchi M, Yokota S. Eating disorder in juvenile fibromyalgia. J Child Adolesc Psychopharmacol. 2016;26(7):653-655. doi: 10.1089/cap.2014.0136
44. Pianucci L, Sonagra M, Greenberg BA, Priestley DR, Gmuca S. Disordered eating among adolescents with chronic pain: The experience of a pediatric rheumatology subspecialty pain clinic. Pediatr Rheumatol Online J. 2021;19(1):16. doi: 10.1186/s12969-021-00506-4
45. Christensen HD, Sheta HM, Morillon MB, Hansen IM. Tophaceous gout in an anorectic patient visualized by dual energy computed tomography (DECT). Am J Case Rep. 2016;17:494-498. doi: 10.12659/ajcr.898542
46. Kinoshita T, Hashimoto Y, Okano T, Nishida Y, Nakamura H. Arthroscopic debridement for gouty arthritis of the knee caused by anorexia nervosa: A case report. J Orthop Sci. 2023;28(1):286- 289. doi: 10.1016/j.jos.2020.04.016
47. Prokopenko EI, Budnikova NA. Diuretic abuse: A nephrologist’s view. The Doctor. 2012;6:12-16 (In Russ.).
48. Gainullina GR, Afanasyeva MA, Lapshina SA. Severe gout in a young woman as a result of eating disorder: A case report. Practical Medicine. 2018;16(7-2):126-129 (In Russ.).
49. Kaleda MI, Nikishina IP, Zokirov NZ, Charlamova AV, Eliseev MS. The experience of using a combination of febuxostat and canakinumab in tophaceous gout complicated by chronic kidney disease in a teenage patient: A case study. Current Pediatrics. 2018;17(5):399-407 (In Russ.). doi: 10.15690/vsp.v17i5.1957
50. Zhang Y, Wang D, Feng Y, Zhang W, Zeng X. Juvenile-onset gout and adipsic diabetes insipidus: A case report and literature review. J Int Med Res. 2018;46(11):4829-4836. doi: 10.1177/0300060518800114
51. Ito S, Torii T, Nakajima A, Iijima T, Murano H, Horiuchi H, et al. Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: A cross-sectional study of a Japanese health insurance database. BMC Pediatr. 2020;20(1):481. doi: 10.1186/s12887-020-02379-0
52. AlAteeq MA, Almaneea A, Althaqeb EK, Aljarallah MF, Alsaleh AE, Alrasheed MA. Uric acid levels in overweight and obese children, and their correlation with metabolic risk factors. Cureus. 2024;16(9):e70160. doi: 10.7759/cureus.70160
53. Gonchar NV, Аvakyan АА, Slizovskiy NV, Sokolova MI, Dudina IV, Prikulis E, et al. Specificities of the clinical signs of metabolic syndrome in children with hyperuricemia. Pediatric Nutrition. 2018;16(1):26-33 (In Russ.). doi: 10.20953/17275784-2018-1-26-33
54. Gonchar NV, Slizovskij NV. Pathogenetic significance of comorbidity of juvenile rheumatoid arthritis and components of metabolic syndrome (literature review). Children’s Medicine of the North-West. 2021;9(4):23-32 (In Russ.).
55. Simeunovic Ostojic M, Maas J. Anorexia nervosa and uric acid beyond gout: An idea worth researching. Int J Eat Disord. 2018;51(2):97-101. doi: 10.1002/eat.22817
56. Kanbay M, Jensen T, Solak Y, Le M, Roncal-Jimenez C, Rivard C, et al. Uric acid in metabolic syndrome: From an innocent bystander to a central player. Eur J Intern Med. 2016;29:3-8. doi: 10.1016/j.ejim.2015.11.026
57. Sautin YY, Johnson RJ. Uric acid: The oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids. 2008;27(6):608-619. doi: 10.1080/15257770802138558
58. Black CN, Bot M, Scheffer PG, Snieder H, Penninx BWJH. Uric acid in major depressive and anxiety disorders. J Affect Disord. 2018;225:684-690. doi: 10.1016/j.jad.2017.09.003
59. Armon G. Serum uric acid and the Five Factor Model of personality: Implications for psychopathological and medical conditions. Pers Individ Dif. 2016;97:277-281. doi: 10.1016/j.paid.2016.03.071
60. Sutin AR, Cutler RG, Camandola S, Uda M, Feldman NH, Cucca F, et al. Impulsivity is associated with uric acid: Evidence from humans and mice. Biol Psychiatry. 2014;75(1):31-37. doi: 10.1016/j.biopsych.2013.02.024
Review
For citations:
Santimov A.V., Grechanyi S.V., Novik G.A., Zhdanova M.V., Slizovskii N.V. Eating disorders in children with rheumatic diseases. Rheumatology Science and Practice. 2025;63(5):510-516. (In Russ.) https://doi.org/10.47360/1995-4484-2025-510-516
Views:
9
Email this article 